| Released | Contributor | Author | Title | Pages | Price |
|---|
| Jun 18, 2013 | New Constructs, LLC | N/A | DNDN: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Jun 18, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (DNDN). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | Jun 18, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | Jun 17, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Dendreon Corporation | 42 | $483 | | Jun 17, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | Jun 16, 2013 | Pechala's Reports | Lubomir Pechala | DENDREON CP (DNDN) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | Jun 14, 2013 | S&P Capital IQ Factual Report | N/A | Dendreon Corp | 11 | $126.50 | | Jun 14, 2013 | Pechala's Reports | Frantisek Pechala | DENDREON CP (DNDN) 12-months forecast | 1 | $15 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) | 105 | $1207.50 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) | 78 | $897 |
|
View All Reports for DNDN ... |
|
|
0.09(2.21%) 3:59PM EDT|After Hours
:
4.00